Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
34,884,647
-
Share change
-
+6,357,925
-
Total reported value
-
$680,875,808
-
Put/Call ratio
-
89%
-
Price per share
-
$19.52
-
Number of holders
-
128
-
Value change
-
+$86,256,980
-
Number of buys
-
71
-
Number of sells
-
69
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2016
As of 31 Mar 2016 Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) had 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,884,647 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, BlackRock Fund Advisors, CITADEL ADVISORS LLC, Jefferies Group LLC, venBio Select Advisor LLC, and COLUMBIA WANGER ASSET MANAGEMENT LLC.
This table shows 128 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.